People who switched from Wegovy or Zepbound to an experimental daily GLP-1 pill kept off most of the weight theyd lost, a new clinical trial found. In contrast, people who stopped injections without ...

(CNN) — Drugmaker Eli Lilly said Thursday that an experimental pill form of popular GLP-1 medications helped people with type 2 diabetes lose an average of nearly 8% of their body weight after 40 ...

A GLP-1 drug in pill form — no needles required — helped people with obesity and Type 2 diabetes lose 10% of their body weight and lower their blood sugar levels, pharmaceutical giant Eli Lilly ...

A pill version of semaglutide — the active ingredient in Ozempic and Wegovy — helped people lose more than 13% of their body weight in a late-stage trial, pharmaceutical giant Novo Nordisk announced ...

Experts describe the development of oral GLP-1 medication as a “pivotal” improvement in the accessibility and adherence to obesity drugs. As of February 2026, only Wegovy and Rybelsus are available in ...

In a new trial, people who switched to the experimental daily GLP-1 pill orforglipron were able to keep off most of the weight they had lost taking Wegovy or Zepbound. People who switched from Wegovy ...